Coronary Artery Bypass Graft Market To Reach $27.66 Billion By 2033

Coronary Artery Bypass Graft Market Growth & Trends

The global coronary artery bypass graft market size is estimated to reach USD 27.66 billion by 2033, registering a CAGR of 3.86% from 2025 to 2033, according to a new report by Grand View Research, Inc. The primary factor driving the industry is an increase in the prevalence of hypertension and cases of myocardial infarction. The American Heart Association estimated that in 2020, Coronary Heart Disease (CHD) was the leading cause of death in the U.S. In addition, the rising technological advancements have led to the development of endoscopic bypass surgery that offers various benefits compared to traditional bypass surgery. Such kind of advancements are contributing to the market growth. Furthermore, the rising geriatric population is influencing market growth.

The aged population is more prone to coronary artery blockages, and studies show that the average age of people undergoing Coronary Artery Bypass Graft (CABG) procedures is approximately older than 66 years. The COVID-19 pandemic had a negative impact on many industries and the CABG market was also highly affected. A study published by the University of Alabama at Birmingham shows an approximately 36% decline in patients undergoing bypass surgery. Many routine procedures were limited due to a workforce shortage. In addition, the supply of raw materials for the devices was limited in the initial phase of COVID-19. Thus, the above-mentioned factors lowered the manufacturing and production of devices.

 Request a free sample copy or view report summary: Coronary Artery Bypass Graft Market Report

Coronary Artery Bypass Graft Market Report Highlights

• By method, the on-pump segment dominated the market in 2024 and accounted for the largest revenue share of 66.80%.

• By surgical procedure, the triple CABG surgery dominated the market in 2024 and accounted for the largest revenue share of 41.76%.

• By end-use, the hospital segment dominated the market in 2024 with a revenue share of 50.74%.

• North America dominated the coronary artery bypass graft market in 2024 and accounted for the largest revenue share of 50.74% owing to a well-established healthcare infrastructure and high healthcare expenditure.

Coronary Artery Bypass Graft Market Segmentation

Grand View Research, Inc. has segmented the global coronary artery bypass graft market based on method, surgical procedure, end-use, and region:

Coronary Artery Bypass Graft Method Outlook (Revenue USD Million, 2021 - 2033)

• Off-pump

• On-pump

• Minimally Invasive Direct CABG (MIDCAB)

Coronary Artery Bypass Graft Surgical Procedure Outlook (Revenue USD Million, 2021 - 2033) (Procedure Volume, In Thousand, 2021 - 2033)

• Single CABG Surgery

• Double CABG Surgery

• Triple CABG Surgery

• Quadruple CABG Surgery

Coronary Artery Bypass Graft End-use Outlook (Revenue USD Million, 2021 - 2033)

• Hospitals

• Cardiology Centers

• Others

Coronary Artery Bypass Graft Regional Outlook (Revenue USD Million, 2021 - 2033) (Procedure Volume, In Thousand, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • Spain

  • Italy

  • France

  • Denmark

  • Norway

  • Sweden

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Argentina

• MEA

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Coronary Artery Bypass Graft Market

• Medtronic

• Terumo Corporation

• Getinge AB

• W. L. Gore & Associates, Inc.

• B. Braun SE

• Abbott.

• LivaNova plc

• Transonic.

• Edwards Lifesciences

• Vascular Graft Solutions